ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
AnaptysBio Inc

AnaptysBio Inc (ANAB)

19.56
-0.27
( -1.36% )
Updated: 13:40:03

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
19.56
Bid
19.56
Ask
19.66
Volume
101,641
19.52 Day's Range 20.66
13.36 52 Week Range 27.50
Market Cap
Previous Close
19.83
Open
19.61
Last Trade
1
@
19.61
Last Trade Time
13:40:34
Financial Volume
$ 2,027,229
VWAP
19.945
Average Volume (3m)
327,005
Shares Outstanding
26,763,081
Dividend Yield
-
PE Ratio
-3.20
Earnings Per Share (EPS)
-6.11
Revenue
17.16M
Net Profit
-163.62M

About AnaptysBio Inc

AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery techno... AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
AnaptysBio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANAB. The last closing price for AnaptysBio was $19.83. Over the last year, AnaptysBio shares have traded in a share price range of $ 13.36 to $ 27.50.

AnaptysBio currently has 26,763,081 shares outstanding. The market capitalization of AnaptysBio is $523.49 million. AnaptysBio has a price to earnings ratio (PE ratio) of -3.20.

ANAB Latest News

Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced...

Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference

SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-5.33-21.414222579324.8924.9419.5230414721.30500634CS
4-4.85-19.86890618624.4125.6219.5239512521.64502754CS
12-4.29-17.987421383623.8527.519.5232700523.22610633CS
261.146.1889250814318.4227.513.3628748221.10795165CS
52-2.6-11.732851985622.1627.513.3625918420.31902187CS
156-2.01-9.3184979137721.5737.8913.3624536223.68110649CS
260-54.22-73.488750338873.7879.099.1632755823.69108765CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.205
(73.24%)
24.48M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.58k
EGOXNext e GO NV
$ 0.0533
(48.06%)
315.42M
NKGNNKGen Biotech Inc
$ 1.25
(45.35%)
1.31M
MNDRMobile health Network Solutions
$ 29.251
(43.60%)
6.25M
YYAIConnexa Sports Technologies Inc
$ 0.9801
(-53.11%)
11.25M
SBFMSunshine Biopharma Inc
$ 1.90
(-42.77%)
9.08M
IPDNProfessional Diversity Network Inc
$ 1.11
(-33.93%)
140.39k
ICUSeaStar Medical Holding Corporation
$ 0.4061
(-24.80%)
4.86M
BGLCBioNexus Gene Lab Corporation
$ 0.6445
(-24.05%)
583.28k
EGOXNext e GO NV
$ 0.054
(50.00%)
315.25M
SQQQProShares UltraPro Short QQQ
$ 12.6457
(4.77%)
141.24M
AGBAAGBA Group Holding Ltd
$ 1.26
(22.33%)
116.04M
SINTSiNtx Technologies Inc
$ 0.0451
(12.75%)
93.09M
BSFCBlue Star Foods Corporation
$ 0.0851
(32.14%)
76.27M

ANAB Discussion

View Posts
gfp927z gfp927z 2 years ago
HighPeaks, The NY Times article was high profile, but the connection to ANAB isn't readily apparent.

Even with the partial sale/monetization of the revenue stream from dostarlimab in December, the drug is also being studied by Glaxo for other cancer types (endometrial, non-small cell lung, ovarian, and mismatch repair deficient solid tumors). One question to answer is whether the monetization deal with Sagard was only for colorectal, or for all the indications? Probably for all, but I'll have to do more research.

ANAB has numerous other programs and a large pile of cash, so looks interesting. But investing in biotech requires a ton of research, but even then you still don't know what you have, and landmines are everywhere. Better to invest in 'what you know', as Buffett recommends :o)




---
👍️0
HighPeaks HighPeaks 2 years ago
Thanks TP. Yeah this has the potential to really be a big mover. So surprised no one has made the connection between this potential miracle drug and $ANAB receiving royalties on it(as it’s originator). GSK is the collaborator who has just commercialized it but it’s ANAB invention.
👍️0
tedpeele tedpeele 2 years ago
Tremendous find HighPeaks. .You have been early on quite a few big movers. I'm thinking this is yet another one.

Will be watching this closely...thanks.
👍️0
HighPeaks HighPeaks 2 years ago
According to this link ANAB gets 8-25% royalties from Dostarlimab. This drug has recently shown phenomenal results in a trial at Memorial Sloan Kettering Hospital. All patients fully recovered from rectal cancer.
https://www.globenewswire.com/fr/news-release/2020/10/26/2114250/0/en/AnaptysBio-and-GlaxoSmithKline-Amend-Strategic-Immuno-Oncology-Collaboration.html
👍️0
TFMG TFMG 4 years ago

$ANAB | #Anaptysbio Spikes After Drug Designation


Nice spike in the afterhours session, lets hope we
can get some continuation tomorrow.
Target $29.00 to Fib Golden Pocket
Also a very large gap to fill at $35.00
AnaptysBio gets orphan drug designation of imsidolimab for pustular psoriasis
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.


👍️0
LoveItInBishop LoveItInBishop 4 years ago
RSI @ 16. laughable. Zacks has positive take. https://finance.yahoo.com/news/anaptysbio-enters-oversold-territory-135501475.html
👍️0
ClayTrader ClayTrader 4 years ago
* * $ANAB Video Chart 11-13-19 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 4 years ago
* * $ANAB Video Chart 11-08-19 * *

Link to Video - click here to watch the technical chart video

👍️0
waterchaser waterchaser 4 years ago
LOL! Twitter PnD. Buyer beware.
👍️0
420man 420man 4 years ago
Once the real bounce starts it will be fast....
👍️0
Crazy Money Crazy Money 4 years ago
$10 to da moon
👍️0
420man 420man 4 years ago
This will bounce..... 15 AH
👍️0
RJ Trotts RJ Trotts 4 years ago
trying to bounce back over $11, hoping for more
👍️0
TaxiCaT TaxiCaT 4 years ago
Ouch -
👍️0
celle celle 5 years ago
Nothing happen here?
👍️0
manny371 manny371 6 years ago
This stock is making noise! Bought in Sept $ANAB
👍️0

Your Recent History

Delayed Upgrade Clock